Examples of Ophthalmic Product in a sentence
Subject to Article 8 (Manufacturing and Technology Transfer), NVS will use Commercially Reasonable Efforts to Develop and obtain Marketing Approval for at least [***] Product in each of the In-Vivo Field and Ex-Vivo Field and for at least [***] Ophthalmic Product that Modulates each Ophthalmic Target.
KR shall promptly notify MN upon the receipt of Regulatory Approvals and of the date of first commercial sale of (i) Ophthalmic Product in the KR Territory or the MN Territory, (ii) Compound and/or Licensed Product for the Optional Indications in the MN Territory or the KR Territory, or (iii) Compound or Licensed Product for the MS Indication in the KR Territory.
By: /s/ Xxxxxxx Xxxxxx --------------------------- APPENDIX A SPECIFICATIONS Glass Code 8013 Corning Incorporated North American Optical division Ophthalmic Product Specifications No. OPS-54, issued 2/01/89, applies to the control of quality of standard fixed tint lens pressings intended for sunglass lenses.
No later than [**] prior to expiration of the Pre-Clinical Development Collaboration Term, the Parties, through the JSC, shall discuss any Ophthalmic Products that are not Royalty-Bearing Products and have not yet advanced to the Pre-IND Filing Opt-Out Period and shall mutually agree which Party shall be the Continuing Party for such Ophthalmic Product.
If a compulsory license is granted to a Third Party with respect to an Ophthalmic Product in any country in the Territory with a royalty rate lower than the applicable royalty rate set forth in this Section 8.3, then the royalty rate to be paid by the Royalty Payor on Net Sales in that country under this Section 8.3 shall be reduced to the rate paid by the compulsory licensee.
The Parties acknowledge that during the Agreement Term, a Royalty Payor's sales practices for the marketing and distribution of an Ophthalmic Product may change to the extent to which the calculation of the payment for royalties on Net Sales may become impractical or even impossible.
Subject to Article 8 (Manufacturing and Technology Transfer), NVS will use Commercially Reasonable Efforts to Develop and obtain Marketing Approval for at least [***] Sickle Cell Product in each of the In-Vivo Field and Ex-Vivo Field and for at least [***] Ophthalmic Product that Modulates each Ophthalmic Target.
Each Ophthalmic Product being jointly Developed and Commercialized by the Parties under this Agreement shall be referred to as a "Profit-Sharing Product", unless and until a Party exercises its Opt-Out Rights with respect to such Profit-Sharing Product.
Following the expiration of the Pre-Clinical Development Collaboration Term, such Ophthalmic Product shall be deemed a Royalty-Bearing Product under this Agreement.
Inspire shall use reasonable efforts to cooperate with Faes to provide, at Faes’ expense, all reasonable assistance reasonably requested by Faes that are necessary for Faes to comply with any law applicable to any Faes Non-Ophthalmic Product or Faes Licensed Ophthalmic Product, including reporting of adverse drug experience reports (and serious adverse drug experiences) to Regulatory Authorities in the applicable countries.